Correlation Between ZyVersa Therapeutics and Editas Medicine
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Editas Medicine, you can compare the effects of market volatilities on ZyVersa Therapeutics and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Editas Medicine.
Diversification Opportunities for ZyVersa Therapeutics and Editas Medicine
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between ZyVersa and Editas is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Editas Medicine go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Editas Medicine
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Editas Medicine. But the stock apears to be less risky and, when comparing its historical volatility, ZyVersa Therapeutics is 1.4 times less risky than Editas Medicine. The stock trades about -0.17 of its potential returns per unit of risk. The Editas Medicine is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 122.00 in Editas Medicine on November 18, 2024 and sell it today you would earn a total of 16.00 from holding Editas Medicine or generate 13.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Editas Medicine
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Editas Medicine |
ZyVersa Therapeutics and Editas Medicine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Editas Medicine
The main advantage of trading using opposite ZyVersa Therapeutics and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Editas Medicine vs. Beam Therapeutics | Editas Medicine vs. Crispr Therapeutics AG | Editas Medicine vs. Caribou Biosciences | Editas Medicine vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |